Seretide Diskus is a medication commonly prescribed for the management of asthma and chronic obstructive pulmonary disease (COPD). It is a combination inhaler that contains two active ingredients: fluticasone propionate and salmeterol xinafoate. Fluticasone propionate is a corticosteroid that helps reduce inflammation in the airways, while salmeterol xinafoate is a long-acting beta2-adrenergic agonist that works as a bronchodilator, relaxing the muscles in the airways to facilitate easier breathing. The medication is typically administered through the Seretide Diskus 50/100 device, which delivers a measured dose of the combination medication. The use of Seretide Diskus is generally aimed at providing long-term control of symptoms rather than providing immediate relief during an acute attack. It is important for individuals using Seretide 100 Diskus to follow their healthcare provider's instructions regarding dosage and frequency.